Artivion, Inc. (AORT)
27.09
+0.10
(+0.37%)
USD |
NYSE |
Sep 01, 16:00
27.10
+0.01
(+0.04%)
Pre-Market: 20:00
Artivion Research and Development Expense (Annual) : 30.99M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 30.99M |
| December 31, 2024 | 28.45M |
| December 31, 2023 | 28.71M |
| December 31, 2022 | 38.88M |
| December 31, 2021 | 35.55M |
| December 31, 2020 | 24.21M |
| December 31, 2019 | 22.96M |
| December 31, 2018 | 23.10M |
| December 31, 2017 | 19.46M |
| December 31, 2016 | 13.45M |
| December 31, 2015 | 10.44M |
| December 31, 2014 | 8.699M |
| December 31, 2013 | 8.454M |
| December 31, 2012 | 7.257M |
| December 31, 2011 | 6.899M |
| December 31, 2010 | 5.923M |
| December 31, 2009 | 5.247M |
| Date | Value |
|---|---|
| December 31, 2008 | 5.309M |
| December 31, 2007 | 4.453M |
| December 31, 2006 | 3.547M |
| December 31, 2005 | 3.724M |
| December 31, 2004 | 3.938M |
| December 31, 2003 | 3.644M |
| December 31, 2002 | 4.597M |
| December 31, 2001 | 4.737M |
| December 31, 2000 | 5.207M |
| December 31, 1999 | 4.396M |
| December 31, 1998 | 4.708M |
| December 31, 1997 | 3.946M |
| December 31, 1996 | 2.807M |
| December 31, 1995 | 2.633M |
| December 31, 1994 | 1.975M |
| December 31, 1993 | 1.384M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alphatec Holdings, Inc. | 76.27M |
| Globus Medical, Inc. | 146.94M |
| Glaukos Corp. | 150.61M |
| TransMedics Group, Inc. | 69.06M |
| PROCEPT BioRobotics Corp. | 71.28M |